Related by context. All words. (Click for frequent words.) 71 ACC AHA SCAI 67 Guideline Update 67 ACC AHA ESC 64 valvular heart 64 postoperative atrial fibrillation 63 ischemic cardiomyopathy 62 ICD implantation 62 Chronic Heart Failure 62 Clinical Practice Guideline 62 ACCF AHA 62 Arterial Hypertension 62 nonoperative 62 UA NSTEMI 62 Initiative K DOQI 61 β blockers 61 perioperative mortality 60 coronary revascularization 60 Thrombolysis 60 aldosterone antagonists 60 NCCN Guidelines ™ 60 antithrombotic therapy 60 MACCE 60 Arch Intern Med 60 ADHF 60 Percutaneous Coronary Intervention 60 Surviving Sepsis Campaign 60 NYHA functional class 60 USpella 60 adenotonsillectomy 60 antihypertensive therapy 60 glycoprotein IIb IIIa inhibitors 60 carotid stenosis 60 NCCN guidelines 60 multivessel disease 59 oral anticoagulation 59 Anticoagulation 59 Fractional Flow Reserve 59 antiplatelet medications 59 Lung Transplantation 59 subtrochanteric 59 Meta analyzes 59 BARI 2D 59 Appropriateness Criteria 59 DVT PE 59 aldosterone antagonist 59 worsening thrombocytopenia 59 postoperative complication 59 ANN INTERN MED 59 Program NCEP 59 stable angina 59 carotid artery stenting CAS 59 HSCT 59 OPCAB 58 Nonsurgical 58 PCWP 58 paroxysmal AF 58 percutaneous coronary interventions 58 Kidney Disease Outcomes 58 Arch Surg 58 antibiotic prophylaxis 58 Venous thromboembolism 58 non valvular atrial 58 antiplatelet drugs 58 Clinical Practice Guidelines 58 intravesical therapy 58 asymptomatic carotid stenosis 58 RECIST Response Evaluation Criteria 58 revascularization procedures 58 postoperative AF 58 left ventricular systolic 58 NCEP ATP III 58 lymphadenectomy 58 systolic dysfunction 58 occlusive disease 58 colon capsule endoscopy 58 reperfusion therapy 58 ALLHAT 58 ISHLT 58 nonfasting triglyceride levels 58 transcatheter aortic valve implantation 58 parathyroidectomy 58 HoLEP 58 NIHSS 58 atrioventricular block 58 Ann Oncol 58 Nesiritide 57 radical nephrectomy 57 Practice Guidelines 57 Carotid Revascularization Endarterectomy vs. 57 hemoglobin A1c levels 57 XIENCE V PROMUS Stent 57 clinicopathological 57 clinicopathologic 57 postoperative mortality 57 Carotid Stenting 57 postsurgical 57 antithrombotic agents 57 NCCN Clinical Practice 57 hepatorenal syndrome 57 morphometric vertebral fractures 57 functional mitral regurgitation 57 Solid Tumors RECIST 57 systolic hypertension 57 Angiographic 57 diabetes mellitus DM 57 Afib 57 Acute Myocardial Infarction 57 CYPHER Stent 57 atherogenic dyslipidemia 57 antiplatelet agents 57 NSTE ACS 57 RECIST 57 GWTG 57 recurrent DVT 57 electrophysiologic 57 endarterectomy 57 Anesthesiologists ASA 57 underwent resection 57 resynchronization therapy 57 Ranolazine 57 KDOQI 57 thrombolytic therapy 57 Acute Decompensated Heart Failure 57 lung resection 57 prospective multicenter study 57 Acute Coronary Syndromes 57 antiarrhythmic drug 57 reinfarction 57 HbA 1c 57 intracranial stenosis 57 IMPROVE HF 57 postoperative pulmonary 57 K DOQI 57 antiplatelet therapy 57 preoperatively 57 Cardiology ESC 57 cytoreductive surgery 57 percutaneous transluminal coronary angioplasty 57 Acute MI 57 Percutaneous Coronary Interventions 57 CTEPH 57 Outpatient Setting 57 tolvaptan 57 dyssynchrony 57 trials RCTs 57 endovascular therapy 57 Solid Tumors 57 ATACAND 57 patients undergoing percutaneous 57 acute coronary syndromes 57 SYNTAX trial 56 atherothrombotic disease 56 colorectal liver metastases 56 Clinical Outcomes Utilizing Revascularization 56 Valvular Heart Disease 56 epidural steroid injections 56 ACTEMRA TM 56 dyslipidaemia 56 perioperative 56 coronary intervention 56 oxycodone CR 56 thrombocytopenic 56 CARE HF 56 BENICAR 56 Doxil ® 56 pericardial effusion 56 oncologic outcomes 56 thoracoscopic lobectomy 56 preoperative chemotherapy 56 invasive aspergillosis 56 percutaneous vertebroplasty 56 BENICAR HCT 56 esophagogastric 56 atherosclerotic renal artery stenosis 56 STEMI patients 56 cardiac resynchronisation therapy 56 infective endocarditis 56 echocardiographic 56 Aggressive Drug Evaluation 56 tirofiban 56 NNT = 56 carotid angioplasty 56 LVEF 56 RYGB 56 Arch Neurol 56 J Am Coll 56 pharmacologic therapy 56 unstable angina pectoris 56 randomized controlled trials RCTs 56 Myocardial Infarction Study 56 prospective multicentre 56 extracranial 56 Coronary artery bypass grafting 56 left ventricular dysfunction 56 revascularizations 56 VADT 56 NCCN Guidelines 56 Coronary Artery Bypass Graft 56 NATRECOR R 56 EULAR 56 periprocedural 56 failure ADHF 56 angioplasty stenting 56 preserved ejection fraction 56 diastolic heart 56 endoscopic ultrasonography 56 Surgical resection 56 acetabular fractures 56 ß blockers 56 hepatectomy 56 beta blocker therapy 56 NSQIP 56 Randomized Controlled Trials 56 Echocardiography ASE 56 Carotid Endarterectomy 56 ARIXTRA 56 NYHA class 56 cardiometabolic risk 56 NYHA 56 Inflammatory Bowel Diseases 56 Sentinel Lymph Node Biopsy 56 FFR guided treatment 56 J Clin Oncol 56 clevidipine 56 aspirin clopidogrel 56 BYSTOLIC 56 Am J Cardiol 56 ICAEL 56 HFSA 56 ICD implantations 56 glycated hemoglobin levels 56 ST Segment Elevation 56 HORIZONS AMI trial 56 myocardial ischemia 56 primidone 56 Response Evaluation Criteria 56 triple nucleoside 56 Systematic Reviews 56 symptomatic carotid stenosis 56 pretest probability 56 eplerenone 56 transcranial Doppler ultrasound 56 Complication rates 55 NYHA Class III 55 ULORIC 55 pulmonary artery banding 55 CCyR 55 nomograms 55 America HFSA 55 contrast echocardiography 55 thrombotic events 55 Index CDAI 55 primary percutaneous coronary 55 Am J Epidemiol 55 progressive dyspnea 55 AHA Guidelines 55 glycated hemoglobin 55 risk stratification 55 inotropic agents 55 DAS# scores 55 preventing venous thromboembolism 55 leukocyte count 55 prospectively stratified 55 Infarction 55 Nephrol Dial Transplant 55 CMV disease 55 nonrandomized 55 renal impairment 55 transurethral resection 55 GWTG Stroke 55 TNM staging 55 See CLINICAL PHARMACOLOGY 55 Taxus Stent 55 arterial thromboembolic events 55 ST Elevation Myocardial 55 binary restenosis 55 Chronic Obstructive Lung 55 prognostic variables 55 NCEP guidelines 55 NATRECOR ® 55 IV NSCLC 55 prespecified secondary 55 NCCTG N# 55 carotid endarterectomy CEA 55 Quality Initiative KDOQI 55 Acute Coronary Syndromes ACS 55 antibiotic regimens 55 meta regression 55 unstable angina UA 55 prostate TURP 55 HNSCC 55 ruboxistaurin 55 intact parathyroid hormone 55 Kaplan Meier analysis 55 SORT OUT III 55 Thoracic Surgeons 55 Pharmacotherapy 55 contrast induced nephropathy 55 patients undergoing CABG 55 TLIF 55 VTE prophylaxis 55 haematologic 55 myocardial viability 55 aortic regurgitation 55 OSAHS 55 troponin T 55 radical prostatectomy RP 55 Subgroup Analysis 55 VAD implantation 55 thyroid nodules 55 colorectal adenoma 55 lipid lowering agents 55 Hyperlipidemia 55 adjuvant therapies 55 metachronous 55 rFVIIa 55 Catheterization 55 Natalizumab 55 Postoperative 55 Invasive Breast Cancer 55 Arrhythmias 55 reflux esophagitis 55 ultrasonographic 55 NCCN Drugs 55 postmenopausal osteoporotic women 55 STEMI 55 Thiazolidinediones 55 Dialysis Outcomes 55 USPSTF 55 NQF endorsed 55 anticoagulation 55 fondaparinux 55 coronary interventions 55 postoperative morbidity 55 #-# Full Text 55 Coronary artery bypass graft 55 hemodialysis patients 55 cardioembolic stroke 55 nondiabetic patients 55 carotid artery stenting 55 DSM IV TR 55 myocardial infarctions 55 hepatic cirrhosis 55 Preoperative 55 vesicoureteral reflux 55 comorbidities 55 ST elevation myocardial 55 Benign Prostatic Hyperplasia BPH 55 alteplase 55 Clinical Guideline 55 acute myocardial infarction 55 afib 55 adjuvant chemotherapy 55 xanthine oxidase inhibitor 55 Reynolds Risk Score 55 venous thromboembolism VTE 55 Vascular Disease 55 reoperations 55 glomerular filtration 55 esophagectomy 55 J Am Soc 55 Castration Resistant Prostate Cancer 55 Cardiac Resynchronization Therapy 55 LAGB 55 acute myocardial infarction MI 55 anticoagulation therapy 55 meniscectomy 55 Antiviral Therapy 55 Clinical Gastroenterology 55 arterial hypertension 55 LV dysfunction 55 revascularization 55 carotid artery stenosis 55 onset atrial fibrillation 55 oral antidiabetic medication 55 sipuleucel T 55 procedural sedation 54 intravenous diuretics 54 postoperative radiotherapy 54 percutaneous nephrolithotomy 54 thickness CIMT 54 renal tumors 54 Disease GOLD 54 radiochemotherapy 54 Outcome Measurement 54 ISHIB 54 echocardiographic parameters 54 serum phosphorous 54 Warfarin Coumadin 54 Venous Thromboembolism 54 myocardial infarction MI 54 K DOQI Clinical 54 angiotensin receptor blockers 54 TMP SMX 54 NAEPP 54 achieved ACR# 54 acutely decompensated congestive heart 54 ipsilateral stroke 54 TAVI 54 FFR guided 54 posttreatment 54 Cardiopulmonary bypass 54 AFib 54 estimated GFR 54 candesartan cilexetil 54 endovascular interventions 54 APPRAISE 54 postoperative pain 54 partial nephrectomy 54 chronic thromboembolic pulmonary 54 Glycemic Control 54 EBUS FNA 54 Stenting Trial CREST 54 varices 54 neoadjuvant chemotherapy 54 J Natl Cancer Inst 54 biochemical recurrence 54 elective PCI 54 preintervention 54 stage IIIB 54 coronary stenosis 54 sUA 54 NYHA Class II 54 Eur Urol 54 HbA 1c levels 54 F FDG PET 54 extrapleural pneumonectomy 54 myocardial revascularization 54 oral diclofenac 54 Group RTOG 54 antimicrobial prophylaxis 54 extracorporeal circulation 54 Fonarow 54 nonfatal MI 54 concomitant medications 54 AST ALT 54 NCCN Updates 54 multivariate Cox 54 degenerative spondylolisthesis 54 Pelvic Organ Prolapse 54 ETDRS 54 TAXUS Express Stent 54 SHPT 54 venous thromboembolic disease 54 nicardipine 54 Cochrane Database Syst Rev 54 Non Alcoholic Fatty 54 pancreatic adenocarcinoma 54 EuroIntervention 54 colon resection 54 NAVISTAR R 54 Am J Gastroenterol 54 antithrombotics 54 vertebral fracture 54 Echocardiographic 54 Breast Surgeons 54 Dabigatran 54 meta analyzes 54 thrombus aspiration 54 ACGME 54 aortic valve stenosis 54 Patient Outcomes 54 Uncontrolled hypertension 54 postdischarge 54 DASH diet 54 DAPT 54 sonographic findings 54 antihypertensive medications 54 arteriography 54 Cardiology ACC 54 intraperitoneal chemotherapy 54 refractory angina 54 polyarticular 54 acutely decompensated heart 54 candesartan 54 atherothrombosis 54 Cancer Incidence Mortality 54 acute myocardial infarction AMI 54 FFR measurements 54 VATS lobectomy 54 bariatric surgical 54 stent implantation 54 undergone radical prostatectomy 54 aortic root replacement 54 NICE SUGAR 54 clopidogrel pretreatment 54 Hypotension 54 solid organ transplantation 54 gynecologic procedures 54 direct thrombin inhibitors 54 Lipid Lowering Treatment 54 ACE Inhibitor 54 sustained virological response 54 pT2 54 NYHA Class IV 54 Venous Forum 54 Cardiotoxicity 54 debulking surgery 54 asymptomatic hyperuricemia 54 macroalbuminuria 54 COR Analyzer 54 GI motility disorders 54 Anti Bacterial Envelope 54 GnRH agonists 54 TAXUS Stent 54 Postoperative complications 54 Diastolic Heart Failure 54 NMIBC 54 Endarterectomy 54 artery stenosis 54 MDRD equation 54 N Engl J 54 Echocardiography 54 nonvertebral fractures 54 Cardiac resynchronization therapy 54 microalbuminuria 54 thrombotic complications 54 carotid IMT 54 lipid lowering drugs 54 Secondary efficacy endpoints 54 inotropic 54 Gastrointestinal Endoscopy ASGE 54 heparin induced thrombocytopenia 54 FASEB J. 54 descending thoracic 54 Carotid artery stenting 54 Bivalirudin 54 thromboprophylaxis 54 Coronary artery bypass 54 Acute myocardial infarction 54 deep venous thromboses 54 angiographically 54 Ejection Fraction 54 MADIT CRT 54 Decompensated Heart Failure 54 rEEG 54 resistant hypertension 54 external beam radiotherapy 54 perioperatively 54 Gynecologic Oncologists 54 intracerebral hemorrhage 54 macrovascular events 54 limb sparing 54 variceal bleeding 54 aminotransferases 54 HbA1c levels 54 amoxicillin clavulanate 54 Circulatory Support 54 microvascular complications 54 Non inferiority 54 RE LY 54 revascularisation 54 retrospective cohort 54 video assisted thoracoscopic 54 NSTEMI 54 Primary endpoints 54 COPD exacerbations 54 valvular disease 54 antithrombotic therapies 54 JCAHO 54 mg BID dose 54 Thal Dex 54 SCr 54 Aortic Dissection 54 upper gastrointestinal bleeding 54 subclinical atherosclerosis 54 BRIM2 54 HYVET 54 T1a 54 serum uric acid 54 OAB symptoms 53 pegylated interferon alfa 2b 53 Eur Respir J 53 directed thrombolysis 53 osteopathic manipulative treatment 53 chemoradiation therapy 53 postop 53 EURIDIS 53 hemoglobin A1c 53 ACUITY 53 Practice Guideline 53 Schizophrenia Bulletin 53 CICA Handbook Sections 53 CYPHER R Sirolimus eluting 53 Acute Ischemic Stroke 53 oncological outcomes 53 undergoing coronary angiography 53 Ischaemic 53 Histologic 53 catheter angiography 53 duplex ultrasonography 53 ExTRACT TIMI 53 MDRD 53 PSADT 53 prostate cancer CaP 53 calculated creatinine clearance 53 ACE inhibitors beta blockers 53 autonomic dysfunction 53 aldosterone antagonist therapy 53 hematologic parameters 53 glulisine 53 confidence interval #.#-#.# 53 mRCC 53 Rheumatology ACR 53 colectomy 53 undergoing elective percutaneous 53 pCR 53 acute myocardial infarctions 53 oral anticoagulant therapy 53 antiplatelet therapies 53 posttransplant 53 hepatic metastases 53 glycosylated hemoglobin HbA1c 53 dual endothelin receptor antagonist 53 DVT prophylaxis 53 mL/min/#.# m 2 53 neoadjuvant treatment 53 AGAF 53 Stop Hypertension DASH diet 53 antireflux surgery 53 PTNS 53 BCIRG 53 percutaneous coronary intervention 53 Follicular Lymphoma 53 PCIs 53 radiographic outcomes 53 death reinfarction 53 intima media thickness 53 postintervention 53 definite stent thrombosis 53 eNO 53 FASLODEX 53 MTWA testing 53 vWD 53 urolithiasis 53 Unstable Angina 53 preoperative 53 atrial arrhythmias 53 beta blockers ACE inhibitors 53 Catheter ablation 53 acute STEMI 53 Patency 53 ICD CRT 53 STRIDE PD 53 thrombolysis 53 thoracic aortic 53 narrow QRS 53 thromboembolic 53 MS DRGs 53 transcranial Doppler 53 ACR# ACR# 53 angiotensin receptor blockers ARBs 53 Dietary Reference Intakes 53 multivariable analyzes 53 metastatic RCC 53 AASLD 53 PICSO ® 53 Fully Covered Stent 53 preoperative diagnosis 53 neoadjuvant therapy 53 nonadherence 53 hemorrhagic complications 53 radiotherapy RT 53 intraobserver 53 platelet reactivity 53 TKAs 53 wedge resection 53 unfractionated heparin UFH 53 interventional therapies 53 Liver biopsy 53 tumor histology 53 carotid endarterectomy 53 Recurrent Stroke 53 BoNTA 53 dietary modification 53 Surgical Treatment 53 Stent Thrombosis 53 angiotensin II receptor blockers 53 AF ablation 53 Eur J Endocrinol 53 unresectable liver cancer 53 Ann Intern Med 53 transthoracic 53 Rhinosinusitis 53 rosuvastatin Crestor 53 fracture fixation 53 Candesartan 53 comorbid conditions 53 external counterpulsation 53 SLN biopsy 53 Ann Emerg Med 53 transesophageal echocardiography 53 ezetimibe simvastatin 53 improves glycemic 53 thromboembolism 53 randomized trials 53 Adjuvant chemotherapy 53 multivariate analyzes 53 NIHSS score 53 intracerebral haemorrhage 53 repeat revascularization 53 MADIT II 53 perioperative complications 53 Antiplatelet 53 HbA1C 53 epithelial ovarian cancer 53 SCD HeFT 53 thrombolytic agents 53 Peripheral Arterial Disease 53 histologic findings 53 nasal obstruction 53 hemodynamic parameters 53 HRCT 53 fundoplication 53 Radiation Therapy Oncology 53 Events MACE 53 pacemaker implantation 53 ICD therapy 53 hematological parameters 53 nonpharmacologic 53 R0 resection 53 detrusor overactivity 53 baseline LDH 53 renal dysfunction 53 eptifibatide 53 nonfatal myocardial infarction 53 thiazide diuretic 53 bypass grafting 53 total hip arthroplasty 53 poor metabolizers 53 ASMBS 53 J Rheumatol 53 Val HeFT 53 Hydroxyurea 53 SABCS 53 Capsule Endoscopy 53 Cardiovascular Angiography 53 Bid increments 53 primary aldosteronism 53 fetal echocardiography 53 mild renal insufficiency 53 lipid lowering therapy 53 Renal dysfunction 53 Edge STudy 53 Stenting 53 ACRIN 53 interobserver 53 eculizumab therapy 53 BI RADS 53 percutaneous drainage 53 peri procedural 53 Thromboembolic 53 mycophenolate mofetil 53 standard chemotherapy regimen 53 cardiogenic shock 53 RCTs 53 total knee arthroplasty 53 cirrhotic patients 53 postoperative 53 fibrinolytic therapy 53 Antihypertensive 53 Carotid 53 osteoid osteoma 53 locoregional 53 bi ventricular pacing 53 pulmonary capillary wedge 53 HAQ DI 53 histologically confirmed 53 ARCOXIA 53 Radical prostatectomy 53 symptomatic VTE 53 Operative mortality 53 Secondary Hyperparathyroidism 53 lipid parameters 53 #F FDG PET 53 GORE TAG Device 53 warfarin therapy 53 BERKELEY CA UroToday.com 53 curative resection 53 psychiatric comorbidities 53 presurgical 53 SPECT MPI 53 carotid stenting 53 laparoscopic fundoplication 53 D dimer 53 Voluntary Consensus 53 Web Content Accessibility 53 comorbidity 53 left ventricular diastolic 53 FDG-PET/CT 53 Dermatol 53 alfuzosin 53 somatoform disorders 53 certolizumab 53 TRITON TIMI 53 pentoxifylline 53 diagnostic angiography 53 everolimus eluting stents 53 pulmonary artery catheters 53 RTOG 53 estimated glomerular filtration 53 Nat Genet 53 ILCOR 53 hsCRP levels 53 RE LY ® 53 allogeneic hematopoietic cell 53 noncardiac surgery 53 hypertensive patients 53 coinfected patients 53 Environ Health Perspect 53 albuminuria 53 ischemic complications 53 pelvic lymphadenectomy 53 radical retropubic prostatectomy 53 obstructive CAD 52 atherosclerotic disease 52 gallstone disease 52 arthroplasties 52 severe exacerbations 52 RE LY trial 52 ENDEAVOR clinical 52 carotid intima media 52 acute coronary syndromes ACS 52 EFNS 52 antihypertensive drugs 52 Crohn Disease Activity 52 XIENCE V demonstrated 52 abacavir Ziagen 52 hypoxemia 52 Ischemic Stroke 52 Peripheral Arterial 52 Systemic Lupus Erythematosus SLE 52 recurrent glioblastoma multiforme 52 cerebrovascular events 52 GHTF 52 Myocardial Infarction 52 metastatic renal cell carcinoma 52 TEVAR 52 Randomized Clinical Trial 52 Outcomes Research ISPOR 52 Bipolar Disorders 52 SLNB 52 Microalbuminuria 52 Cystatin C 52 UKPDS 52 HES CEL 52 interpersonal psychotherapy 52 statistically significant p = 52 ACUITY trial 52 Cardiorespiratory fitness 52 Patient Registry 52 nonfasting triglycerides 52 Cardiac Failure 52 underwent CABG 52 hip resurfacing arthroplasty 52 sidebranch 52 haemodynamic 52 ximelagatran 52 carotid artery narrowing 52 resuscitated cardiac arrest 52 levosimendan 52 bifurcation lesions 52 cystatin C 52 subclinical hypothyroidism 52 Free Full Text 52 overt nephropathy 52 glycemia 52 Carotid Artery Stenting 52 histological subtype 52 Prospective Randomized 52 calcium antagonists 52 NSABP B 52 resected pancreatic cancer 52 Prehypertension 52 achieved CCyR 52 Clinical Outcome 52 refractory ischemia 52 retransplantation 52 chest radiographs 52 knee arthroplasty 52 GP IIb IIIa inhibitors 52 sirolimus eluting stents 52 Cardiovascular Outcomes 52 ARB telmisartan 52 titrated glipizide 52 left ventricular LV 52 Clinical Documentation 52 carotid surgery 52 glomerular filtration rate 52 Stent thrombosis 52 MRgFUS 52 diagnosing coronary artery 52 Hb A1C 52 number NCT# ClinicalTrials.gov 52 repair TEVAR 52 retrospective observational study 52 Skin sterol 52 erythrocyte sedimentation rate 52 mg/m2 dose 52 J Pediatr 52 topical calcineurin inhibitors 52 MMSE scores 52 CRT ICD 52 Myocardial Ischemia 52 Renal Cell Carcinoma RCC 52 Vertebroplasty 52 chemoradiotherapy 52 Implantable Cardioverter Defibrillator 52 Rate ORR 52 reflux symptoms 52 Heart Failure Therapies 52 noninferiority 52 sotalol 52 immunosuppressive agents 52 efficacy evaluable 52 Quality Forum NQF 52 locoregional recurrence 52 logistic regression models 52 A1c levels 52 ejection fraction 52 hypertension diabetes mellitus 52 mechanical thrombectomy 52 percutaneous intervention 52 cardiovascular morbidity 52 postprocedure 52 STEMIs 52 cystoid macular edema 52 nonoperative treatment 52 teriflunomide 52 endoscopic retrograde 52 undergoing CABG 52 Digital Mammographic Imaging 52 Tonsillectomy 52 serum GGT 52 kidney urologic 52 Cochrane Database 52 HCV SPRINT 52 NAFLD 52 bronchial hyperresponsiveness 52 antidiabetic therapy 52 perioperative morbidity 52 PROTECT II 52 chlorthalidone 52 biventricular pacing 52 cerebral infarction 52 preoperative PSA 52 Cypher Stent 52 adenoma recurrence 52 clinico pathological 52 AHFS 52 mediastinitis 52 glycated hemoglobin HbA1c 52 tachyarrhythmia 52 DAS# CRP 52 Arteriovenous 52 vertebral compression fractures 52 multimodality therapy 52 cerebral vasospasm 52 inhospital 52 idraparinux 52 nonobstructive CAD 52 Ann Rheum Dis 52 Abdominal ultrasound 52 malperfusion 52 antiarrhythmic medications 52 T2DM 52 empyema 52 pretransplant 52 VerifyNow P#Y# Test 52 oral FTY# 52 kidney transplant recipients 52 Hemodynamic 52 HIPEC 52 VT VF 52 coronary arterial 52 undergoing Percutaneous Coronary 52 Urinary Incontinence 52 surgical revascularization 52 chronic rhinosinusitis 52 femoral shaft fractures 52 Renal Physicians 52 TURBT 52 Cardiovascular Interventions 52 OCPs 52 chronic myocardial ischemia 52 TMS Therapy 52 ICD implants 52 Stent Restenosis 52 5-FU/LV 52 AAO HNSF 52 venous thrombosis 52 elevated LDL cholesterol 52 dobutamine stress 52 CI -#.# 52 everolimus eluting stent 52 nonfatal myocardial infarction MI 52 acute coronary syndrome 52 AJCC 52 ECASS